_id
69105becccc777a4e85d5829
Ticker
DNAG
Name
DNAPrint Genomics Inc
Exchange
OTCCE
Address
1621 West University Parkway, Sarasota, FL, United States, 34243
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
Description
DNAPrint Genomics, Inc. engages in the development and marketing of genetic testing products and services. It offers AncestryByDNA, a pan-chromosomal assay for genetic ancestry; EurasianDNA, which measures European sub-ancestry; EuropeanDNA, which reports a customer's proportional basic continental European ancestry; DNAWitness to determine genetic heritage from DNA samples obtained from crime scenes; RETINOME, which provides a physical portrait of a person of interest for a detective based on a DNA sample from a crime scene or remains of an individual; RETINOME, which allows infer eye color from DNA; and GenomeLab SNPstream Genotyping System, which offers genotyping rates and uses a multiplexing format to generate data with the minimum of reagents. The company serves forensic science, genealogical research, consumer products, and pharmaceutical development clients. DNAPrint Genomics, Inc. was formerly known as Lexington Energy, Inc. The company was incorporated in 1983 and is based in Sarasota, Florida with a subsidiary in Leverkusen, Germany.
Last Close
-
Volume
-
Current Price
0
Change
0
Last Updated
2026-01-02T12:42:03.071Z
Image
data:image/webp;base64,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
Ipo Date
-
Market Cap
386765
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2007-09-30
Revenue
227562
Cost Of Revenue
234150
Gross Profit
-6588
Operating Expenses
1890018
Operating Income
-1662456
Interest Expense
221981
Pretax Income
-1881327
Net Income
-1881327
Eps
-
Dividends Per Share
-
Shares Outstanding
0
Income Tax Expense
0
EBITDA
-
Operating Margin
-730.55079494819
Total Other Income Expense Net
-218871
Cash
134347
Short Term Investments
-
Receivables
1425138
Inventories
289160
Total Current Assets
1888145
Property Plant Equipment
1045990
Total Assets
3112863
Payables
2648850
Short Term Debt
174805
Long Term Debt
212888
Total Liabilities
11499788
Equity
-8386925
Bs_currency_symbol
USD
Depreciation
131795
Change In Working Capital
-
Cash From Operations
-1361795
Capital Expenditures
1603
Cash From Investing
1349647
Cash From Financing
-338026
Net Change In Cash
-373619
Cf_currency_symbol
USD
PE
-
PB
-
ROE
22.43166595623545
ROA
-60.43719238527362
FCF
-1363398
Fcf Percent
-5.991325440978723
Piotroski FScore
1
Health Score
41
Deep Value Investing Score
1.5
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
6.3
Garp Investing Score
2.5
Growth Investing Score
2
Momentum Investing Score
3
Net Net Investing Score
1
Quality Investing Score
2
Value Investing Score
2.5
Quarters > 0 > quarter
2007-09-30
Quarters > 0 > income Statement > revenue
227562
Quarters > 0 > income Statement > cost Of Revenue
234150
Quarters > 0 > income Statement > gross Profit
-6588
Quarters > 0 > income Statement > operating Expenses
1890018
Quarters > 0 > income Statement > operating Income
-1662456
Quarters > 0 > income Statement > interest Expense
221981
Quarters > 0 > income Statement > pretax Income
-1881327
Quarters > 0 > income Statement > net Income
-1881327
Quarters > 0 > income Statement > eps
-
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
-
Quarters > 0 > income Statement > income Tax Expense
0
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-730.55079494819
Quarters > 0 > income Statement > total Other Income Expense Net
-218871
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
134347
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
1425138
Quarters > 0 > balance Sheet > inventories
289160
Quarters > 0 > balance Sheet > total Current Assets
1888145
Quarters > 0 > balance Sheet > property Plant Equipment
1045990
Quarters > 0 > balance Sheet > total Assets
3112863
Quarters > 0 > balance Sheet > payables
2648850
Quarters > 0 > balance Sheet > short Term Debt
174805
Quarters > 0 > balance Sheet > long Term Debt
212888
Quarters > 0 > balance Sheet > total Liabilities
11499788
Quarters > 0 > balance Sheet > equity
-8386925
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-1881327
Quarters > 0 > cash Flow > depreciation
131795
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-1361795
Quarters > 0 > cash Flow > capital Expenditures
1603
Quarters > 0 > cash Flow > cash From Investing
1349647
Quarters > 0 > cash Flow > cash From Financing
-338026
Quarters > 0 > cash Flow > net Change In Cash
-373619
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-
Quarters > 0 > ratios > PB
-
Quarters > 0 > ratios > ROE
22.43166595623545
Quarters > 0 > ratios > ROA
-60.43719238527362
Quarters > 0 > ratios > FCF
-1363398
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-5.991325440978723
Quarters > 0 > health Score
41
Quarters > 1 > quarter
2007-06-30
Quarters > 1 > income Statement > revenue
476987
Quarters > 1 > income Statement > cost Of Revenue
391251
Quarters > 1 > income Statement > gross Profit
85736
Quarters > 1 > income Statement > operating Expenses
1933451
Quarters > 1 > income Statement > operating Income
-1456464
Quarters > 1 > income Statement > interest Expense
363856
Quarters > 1 > income Statement > pretax Income
-1696992
Quarters > 1 > income Statement > net Income
-1696992
Quarters > 1 > income Statement > eps
-
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
-
Quarters > 1 > income Statement > income Tax Expense
0
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-305.34668659732864
Quarters > 1 > income Statement > total Other Income Expense Net
-240528
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
507966
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
2772464
Quarters > 1 > balance Sheet > inventories
203960
Quarters > 1 > balance Sheet > total Current Assets
3591924
Quarters > 1 > balance Sheet > property Plant Equipment
1150847
Quarters > 1 > balance Sheet > total Assets
4946494
Quarters > 1 > balance Sheet > payables
2986383
Quarters > 1 > balance Sheet > short Term Debt
199250
Quarters > 1 > balance Sheet > long Term Debt
214168
Quarters > 1 > balance Sheet > total Liabilities
11967592
Quarters > 1 > balance Sheet > equity
-7021098
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-1696992
Quarters > 1 > cash Flow > depreciation
134709
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
-1208049
Quarters > 1 > cash Flow > capital Expenditures
1603
Quarters > 1 > cash Flow > cash From Investing
2006050
Quarters > 1 > cash Flow > cash From Financing
-561809
Quarters > 1 > cash Flow > net Change In Cash
238621
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-
Quarters > 1 > ratios > PB
-
Quarters > 1 > ratios > ROE
24.169894794233038
Quarters > 1 > ratios > ROA
-34.30696570136343
Quarters > 1 > ratios > FCF
-1209652
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-2.5360271873237634
Quarters > 1 > health Score
41
Quarters > 2 > quarter
2007-03-31
Quarters > 2 > income Statement > revenue
701013
Quarters > 2 > income Statement > cost Of Revenue
514698
Quarters > 2 > income Statement > gross Profit
186315
Quarters > 2 > income Statement > operating Expenses
2146815
Quarters > 2 > income Statement > operating Income
-1445802
Quarters > 2 > income Statement > interest Expense
456910
Quarters > 2 > income Statement > pretax Income
2888174
Quarters > 2 > income Statement > net Income
2888174
Quarters > 2 > income Statement > eps
-
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
-
Quarters > 2 > income Statement > income Tax Expense
0
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-206.2446773454986
Quarters > 2 > income Statement > total Other Income Expense Net
4333976
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
269345
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
4803489
Quarters > 2 > balance Sheet > inventories
129735
Quarters > 2 > balance Sheet > total Current Assets
5318554
Quarters > 2 > balance Sheet > property Plant Equipment
1132352
Quarters > 2 > balance Sheet > total Assets
6675087
Quarters > 2 > balance Sheet > payables
3021332
Quarters > 2 > balance Sheet > short Term Debt
201250
Quarters > 2 > balance Sheet > long Term Debt
201814
Quarters > 2 > balance Sheet > total Liabilities
12428692
Quarters > 2 > balance Sheet > equity
-5753605
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
2888174
Quarters > 2 > cash Flow > depreciation
131947
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-1246634
Quarters > 2 > cash Flow > capital Expenditures
2000
Quarters > 2 > cash Flow > cash From Investing
1948883
Quarters > 2 > cash Flow > cash From Financing
-1028397
Quarters > 2 > cash Flow > net Change In Cash
-325336
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-
Quarters > 2 > ratios > PB
-
Quarters > 2 > ratios > ROE
-50.19764130488624
Quarters > 2 > ratios > ROA
43.26796040261348
Quarters > 2 > ratios > FCF
-1248634
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-1.7811852276633957
Quarters > 2 > health Score
36
Quarters > 3 > quarter
2006-12-31
Quarters > 3 > income Statement > revenue
525646
Quarters > 3 > income Statement > cost Of Revenue
344740
Quarters > 3 > income Statement > gross Profit
180906
Quarters > 3 > income Statement > operating Expenses
2267055
Quarters > 3 > income Statement > operating Income
-1741409
Quarters > 3 > income Statement > interest Expense
2641402
Quarters > 3 > income Statement > pretax Income
-3860649
Quarters > 3 > income Statement > net Income
-3860649
Quarters > 3 > income Statement > eps
-
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
-
Quarters > 3 > income Statement > income Tax Expense
0
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-331.28930877434624
Quarters > 3 > income Statement > total Other Income Expense Net
-2119240
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
594681
Quarters > 3 > balance Sheet > short Term Investments
7903053
Quarters > 3 > balance Sheet > receivables
74573
Quarters > 3 > balance Sheet > inventories
96432
Quarters > 3 > balance Sheet > total Current Assets
8783137
Quarters > 3 > balance Sheet > property Plant Equipment
1238207
Quarters > 3 > balance Sheet > total Assets
10269576
Quarters > 3 > balance Sheet > payables
3010329
Quarters > 3 > balance Sheet > short Term Debt
239997
Quarters > 3 > balance Sheet > long Term Debt
175173
Quarters > 3 > balance Sheet > total Liabilities
13980211
Quarters > 3 > balance Sheet > equity
-3710635
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-3860649
Quarters > 3 > cash Flow > depreciation
131285
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-324372
Quarters > 3 > cash Flow > capital Expenditures
161395
Quarters > 3 > cash Flow > cash From Investing
393243
Quarters > 3 > cash Flow > cash From Financing
405405
Quarters > 3 > cash Flow > net Change In Cash
483892
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-
Quarters > 3 > ratios > PB
-
Quarters > 3 > ratios > ROE
104.04281207933413
Quarters > 3 > ratios > ROA
-37.593071028443624
Quarters > 3 > ratios > FCF
-485767
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-0.9241333521038874
Quarters > 3 > health Score
41
Annuals > 0 > quarter
2006-12-31
Annuals > 0 > income Statement > revenue
2433000
Annuals > 0 > income Statement > cost Of Revenue
1678932
Annuals > 0 > income Statement > gross Profit
754068
Annuals > 0 > income Statement > operating Expenses
11300169
Annuals > 0 > income Statement > operating Income
-8867169
Annuals > 0 > income Statement > interest Expense
0
Annuals > 0 > income Statement > pretax Income
-12348364
Annuals > 0 > income Statement > net Income
-12348364
Annuals > 0 > income Statement > eps
-
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
-
Annuals > 0 > income Statement > income Tax Expense
0
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-364.454130702836
Annuals > 0 > income Statement > total Other Income Expense Net
-3481195
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
594681
Annuals > 0 > balance Sheet > short Term Investments
7903053
Annuals > 0 > balance Sheet > receivables
74573
Annuals > 0 > balance Sheet > inventories
96432
Annuals > 0 > balance Sheet > total Current Assets
8783137
Annuals > 0 > balance Sheet > property Plant Equipment
1238207
Annuals > 0 > balance Sheet > total Assets
10269576
Annuals > 0 > balance Sheet > payables
3010329
Annuals > 0 > balance Sheet > short Term Debt
239997
Annuals > 0 > balance Sheet > long Term Debt
175173
Annuals > 0 > balance Sheet > total Liabilities
13980211
Annuals > 0 > balance Sheet > equity
-3710635
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-12348364
Annuals > 0 > cash Flow > depreciation
539557
Annuals > 0 > cash Flow > change In Working Capital
-
Annuals > 0 > cash Flow > cash From Operations
-5781789
Annuals > 0 > cash Flow > capital Expenditures
391445
Annuals > 0 > cash Flow > cash From Investing
163193
Annuals > 0 > cash Flow > cash From Financing
4405246
Annuals > 0 > cash Flow > net Change In Cash
-1211965
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-
Annuals > 0 > ratios > PB
-
Annuals > 0 > ratios > ROE
332.7830411775882
Annuals > 0 > ratios > ROA
-120.24219889896135
Annuals > 0 > ratios > FCF
-6173234
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-2.5372930538429923
Annuals > 0 > health Score
41
Annuals > 1 > quarter
2005-12-31
Annuals > 1 > income Statement > revenue
1275503
Annuals > 1 > income Statement > cost Of Revenue
950472
Annuals > 1 > income Statement > gross Profit
325031
Annuals > 1 > income Statement > operating Expenses
5937403
Annuals > 1 > income Statement > operating Income
-4661900
Annuals > 1 > income Statement > interest Expense
0
Annuals > 1 > income Statement > pretax Income
-8715852
Annuals > 1 > income Statement > net Income
-8715852
Annuals > 1 > income Statement > eps
-
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
-
Annuals > 1 > income Statement > income Tax Expense
0
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-365.49502431589735
Annuals > 1 > income Statement > total Other Income Expense Net
-4053952
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
1806646
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
101852
Annuals > 1 > balance Sheet > inventories
298685
Annuals > 1 > balance Sheet > total Current Assets
2470613
Annuals > 1 > balance Sheet > property Plant Equipment
1229133
Annuals > 1 > balance Sheet > total Assets
6310109
Annuals > 1 > balance Sheet > payables
1152711
Annuals > 1 > balance Sheet > short Term Debt
1069915
Annuals > 1 > balance Sheet > long Term Debt
126458
Annuals > 1 > balance Sheet > total Liabilities
10400243
Annuals > 1 > balance Sheet > equity
-4090281
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-8715852
Annuals > 1 > cash Flow > depreciation
224077
Annuals > 1 > cash Flow > change In Working Capital
-
Annuals > 1 > cash Flow > cash From Operations
-3605877
Annuals > 1 > cash Flow > capital Expenditures
123596
Annuals > 1 > cash Flow > cash From Investing
-2195918
Annuals > 1 > cash Flow > cash From Financing
6629966
Annuals > 1 > cash Flow > net Change In Cash
828111
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-
Annuals > 1 > ratios > PB
-
Annuals > 1 > ratios > ROE
213.0868759383524
Annuals > 1 > ratios > ROA
-138.12522097478822
Annuals > 1 > ratios > FCF
-3729473
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-2.92392334631906
Annuals > 1 > health Score
40
Annuals > 2 > quarter
2004-12-31
Annuals > 2 > income Statement > revenue
785632
Annuals > 2 > income Statement > cost Of Revenue
507927
Annuals > 2 > income Statement > gross Profit
277705
Annuals > 2 > income Statement > operating Expenses
4120050
Annuals > 2 > income Statement > operating Income
-3334418
Annuals > 2 > income Statement > interest Expense
0
Annuals > 2 > income Statement > pretax Income
-3734982
Annuals > 2 > income Statement > net Income
-3734982
Annuals > 2 > income Statement > eps
-
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
-
Annuals > 2 > income Statement > income Tax Expense
0
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
-424.4249215917885
Annuals > 2 > income Statement > total Other Income Expense Net
-400564
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
978535
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
237249
Annuals > 2 > balance Sheet > inventories
65279
Annuals > 2 > balance Sheet > total Current Assets
1406128
Annuals > 2 > balance Sheet > property Plant Equipment
380262
Annuals > 2 > balance Sheet > total Assets
1791390
Annuals > 2 > balance Sheet > payables
352718
Annuals > 2 > balance Sheet > short Term Debt
161000
Annuals > 2 > balance Sheet > long Term Debt
29000
Annuals > 2 > balance Sheet > total Liabilities
1695855
Annuals > 2 > balance Sheet > equity
95135
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-3734982
Annuals > 2 > cash Flow > depreciation
182774
Annuals > 2 > cash Flow > change In Working Capital
-
Annuals > 2 > cash Flow > cash From Operations
-3764425
Annuals > 2 > cash Flow > capital Expenditures
56969
Annuals > 2 > cash Flow > cash From Investing
-250652
Annuals > 2 > cash Flow > cash From Financing
4727691
Annuals > 2 > cash Flow > net Change In Cash
712614
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-
Annuals > 2 > ratios > PB
-
Annuals > 2 > ratios > ROE
-3925.9809744047934
Annuals > 2 > ratios > ROA
-208.49630733676085
Annuals > 2 > ratios > FCF
-3821394
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-4.8641017677487675
Annuals > 2 > health Score
18
Annuals > 3 > quarter
2003-12-31
Annuals > 3 > income Statement > revenue
709638
Annuals > 3 > income Statement > cost Of Revenue
432224
Annuals > 3 > income Statement > gross Profit
277414
Annuals > 3 > income Statement > operating Expenses
6944408
Annuals > 3 > income Statement > operating Income
-6234770
Annuals > 3 > income Statement > interest Expense
0
Annuals > 3 > income Statement > pretax Income
-7789905
Annuals > 3 > income Statement > net Income
-7789905
Annuals > 3 > income Statement > eps
-
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
-
Annuals > 3 > income Statement > income Tax Expense
0
Annuals > 3 > income Statement > EBITDA
-
Annuals > 3 > income Statement > operating Margin
-878.5845741067981
Annuals > 3 > income Statement > total Other Income Expense Net
-1555135
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
265921
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
432258
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
1001256
Annuals > 3 > balance Sheet > property Plant Equipment
282305
Annuals > 3 > balance Sheet > total Assets
1288561
Annuals > 3 > balance Sheet > payables
582602
Annuals > 3 > balance Sheet > short Term Debt
833272
Annuals > 3 > balance Sheet > long Term Debt
470000
Annuals > 3 > balance Sheet > total Liabilities
3325656
Annuals > 3 > balance Sheet > equity
-2037095
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-7789905
Annuals > 3 > cash Flow > depreciation
125640
Annuals > 3 > cash Flow > change In Working Capital
-
Annuals > 3 > cash Flow > cash From Operations
-1106857
Annuals > 3 > cash Flow > capital Expenditures
14165
Annuals > 3 > cash Flow > cash From Investing
-14165
Annuals > 3 > cash Flow > cash From Financing
1375163
Annuals > 3 > cash Flow > net Change In Cash
254141
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-
Annuals > 3 > ratios > PB
-
Annuals > 3 > ratios > ROE
382.4026370885992
Annuals > 3 > ratios > ROA
-604.5429746826111
Annuals > 3 > ratios > FCF
-1121022
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-1.5797096547817338
Annuals > 3 > health Score
40
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
22.43166595623545
Profitability > metrics > ROA
-99.63890485105752
Profitability > metrics > Net Margin
-8.267316159991562
Profitability > final Score
40
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-7.489181506525333
Risk > final Score
0
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.6686882781359621
Liquidity > metrics > Quick Ratio
0.5662819997485529
Liquidity > final Score
38
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
40
Prev Profitabilities > 1
60
Prev Profitabilities > 2
40
Prev Risks > 0
14
Prev Risks > 1
17
Prev Risks > 2
27
Prev Liquidities > 0
78
Prev Liquidities > 1
91
Prev Liquidities > 2
100
Updated At
2026-01-20T21:43:08.169Z
DNAPrint Genomics, Inc. engages in the development and marketing of genetic testing products and services. It offers AncestryByDNA, a pan-chromosomal assay for genetic ancestry; EurasianDNA, which measures European sub-ancestry; EuropeanDNA, which reports a customer's proportional basic continental European ancestry; DNAWitness to determine genetic heritage from DNA samples obtained from crime scenes; RETINOME, which provides a physical portrait of a person of interest for a detective based on a DNA sample from a crime scene or remains of an individual; RETINOME, which allows infer eye color from DNA; and GenomeLab SNPstream Genotyping System, which offers genotyping rates and uses a multiplexing format to generate data with the minimum of reagents. The company serves forensic science, genealogical research, consumer products, and pharmaceutical development clients. DNAPrint Genomics, Inc. was formerly known as Lexington Energy, Inc. The company was incorporated in 1983 and is based in Sarasota, Florida with a subsidiary in Leverkusen, Germany.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2007-09-30)
Health Score
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 0.00% of the total shares of DNAPrint Genomics Inc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2007-09-30)
(Last Updated 2007-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2007-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2007-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.